Showing 541 - 560 results of 10,572 for search '"Tumor"', query time: 0.12s Refine Results
  1. 541

    Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Olivier Michielin, Philippe Guillaume, Melita Irving, Patrick Reichenbach, Vincent Zoete, Elise Gray-Gaillard, Evangelos Stefanidis, Aikaterini Semilietof, Julien Pujol, Alessia D'Esposito

    Published 2024-12-01
    “…A variety of approaches are being taken to augment tumor control by ACT including TCR affinity-optimization and T-cell coengineering strategies to address the suppressive tumor microenvironment (TME). …”
    Get full text
    Article
  2. 542

    Transition Yet Energy Consuming for Tumor Growth Regulated by the Colored Microenvironment by Leiyan Chen, Yan Wang, Qingqing Li, Haohua Wang

    Published 2023-01-01
    “…Transition or metastasis is a main characteristic of tumor developmental processes. However, the mechanism behind the transition and what costs involved are obscure when the tumor is exposed to a colored microscopic environment. …”
    Get full text
    Article
  3. 543

    Gastric Glomus Tumor: A Rare Cause of Upper Gastrointestinal Bleeding by Yoshinori Handa, Mikihiro Kano, Mayumi Kaneko, Naoki Hirabayashi

    Published 2015-01-01
    “…Histological and immunohistological analysis revealed the tumor to be a gastric glomus tumor. Gastric submucosal tumors remain challenging to diagnose preoperatively as they show a variety of radiologic and clinicopathologic features and are associated with the risk of bleeding upon biopsy, as is indicated in the guidelines for gastric submucosal tumors. …”
    Get full text
    Article
  4. 544

    Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells by Amanda C. Stacer, Hanxiao Wang, Joseph Fenner, Joseph S. Dosch, Anna Salomonnson, Kathryn E. Luker, Gary D. Luker, Alnawaz Rehemtulla, Brian D. Ross

    Published 2015-08-01
    “…Tumor-initiating cells, also designated as cancer stem cells, are proposed to constitute a subpopulation of malignant cells central to tumorigenesis, metastasis, and treatment resistance. …”
    Get full text
    Article
  5. 545

    Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with or Mutation by Jialiang Wang MM, Chang Guo BMed, Jiexiao Wang MM, Xiaopeng Zhang BS, Jian Qi PhD, Xiang Huang MM, Zongtao Hu MM, Hongzhi Wang MM, Bo Hong PhD

    Published 2025-01-01
    “…Introduction EGFR and KRAS mutations are frequently detected in lung adenocarcinoma (LUAD). Tumor mutational signature (TMS) determination is an approach to identify somatic mutational patterns associated with pathogenic factors. …”
    Get full text
    Article
  6. 546
  7. 547

    Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors by Estela Regina Ramos Figueira, Julia Fray Ribeiro, Thiago Costa Ribeiro, Ricardo Jureidini, Guilherme Naccache Namur, Thiago Nogueira Costa, Telesforo Bacchella, Ivan Cecconello

    Published 2021-01-01
    “…The incidence of small nonfunctioning neuroendocrine pancreatic tumors (NF-PNETs) has been increasing systematically in the last few decades. …”
    Get full text
    Article
  8. 548
  9. 549
  10. 550

    Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game by Paqui G. Través, Alfonso Luque, Sonsoles Hortelano

    Published 2012-01-01
    “…The interaction between tumor progression and innate immune system has been well established in the last years. …”
    Get full text
    Article
  11. 551

    Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy by Shixue Chen, Lingling Li, Fan Zhang, Yu Wang, Yi Hu, Lei Zhao

    Published 2019-01-01
    “…This review considers various IgG-like BsAb generation approaches, summarizes the clinical applications of promising new BsAbs, and describes the mechanism of BsAbs in tumor therapy.…”
    Get full text
    Article
  12. 552

    Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects by Yelei Guo, Yao Wang, Weidong Han

    Published 2016-01-01
    “…Many studies have struggled to improve the clinical responses to and benefits of CART-cell treatment of solid tumors. In this review, the status quo of CART cells and their clinical applications for solid tumors will be summarized first. …”
    Get full text
    Article
  13. 553
  14. 554

    Nonislet Cell Tumor Hypoglycemia in a Patient with Adrenal Cortical Carcinoma by Se Won Kim, Seung-Eun Lee, Young Lyun Oh, Seokhwi Kim, Sun Hee Park, Jae Hyeon Kim

    Published 2016-01-01
    “…Nonislet cell tumor hypoglycemia (NICTH) is a rare but serious paraneoplastic syndrome in which a tumor secretes incompletely processed precursors of insulin-like growth factor-II (IGF-II), causing hypoglycemia. …”
    Get full text
    Article
  15. 555
  16. 556

    Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor by James Benjamin Gleason, Basheer Tashtoush, Maria Julia Diacovo

    Published 2016-01-01
    “…Biphasic malignant pleural mesothelioma is a rare malignant tumor, usually presenting as a pleural-based mass in a patient with history of chronic asbestos exposure. …”
    Get full text
    Article
  17. 557
  18. 558
  19. 559

    Coexistence of Primary GEJ Adenocarcinoma and Pedunculated Gastric Gastrointestinal Stromal Tumor by Aroub Alkaaki, Basma Abdulhadi, Murad Aljiffry, Mohammed Nassif, Haneen Al-Maghrabi, Ashraf A. Maghrabi

    Published 2018-01-01
    “…Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive system, although they account for only 0.1–3% of all gastrointestinal (GI) malignancies. …”
    Get full text
    Article
  20. 560

    Case Report of Rare Parathyroid Tumor with Atypical Presentation and Early Diagnosis by Érika Mayumi Ikeda Cavamura, Fabiane Karen Miyake, Jéssica Yachio Wiezel, Laura Schwartz Maranho, Luis Felipe Inglês Takada, Renata Cassitas Mendonça, Tamila Sohn Fagundes

    Published 2022-01-01
    “…To raise the suspicion of parathyroid carcinoma, it is essential to perform the correlation of the clinical picture, biochemical values, and imaging exams, but to obtain the definitive diagnosis, intraoperative recognition of the tumor and the result of the histopathological examination of the resected tumor are necessary.…”
    Get full text
    Article